Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Exclusive: Astellas partners with Boston ‘miniproteins’ startup

Chris Bahl believes AI can help make tiny proteins capable of doing things that bigger and more traditional proteins like antibodies struggle to do. And now the Japanese drugmaker Astellas is buying into his vision ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 20 October →